Compare ARK Genomic Revolution ETF (ARKG) vs Grab Holdings Ltd. (GRAB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Grab Holdings Ltd. — how do they compare? ARK Genomic Revolution ETF trades at $41.2, while Grab Holdings Ltd. trades at $4 (market cap $16.07B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Grab Holdings Ltd. nearer its low. Which is the better fit depends on your goals.
| ARKG | GRAB | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $6.45 |
52-Week Low | $23.09 | $3.27 |
Market Cap | — | $16.07B |
Enterprise Value | — | $11.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Grab Holdings trades at $3.93, up 1.29% with a bullish technical signal. The company achieved profitability in 2025 with $268M net income and 7.95% margin, showing strong revenue growth from $2.8B to $3.4B. Analyst consensus is strongly bullish with 11 buy ratings and a $5.45 price target, representing 39% upside potential. Recent news highlights investor interest despite Uber CEO's board departure causing temporary volatility.
Grab presents a compelling growth story with improving fundamentals and strong analyst support. Key opportunities include Southeast Asia market expansion and super-app ecosystem growth. Risks include intense competition, execution challenges, and market volatility. The stock offers significant upside to consensus targets but requires monitoring of quarterly execution and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Grab Holdings Ltd.
Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →
